CRO PHARMExcel today announced the launch of Dot Compliance eQMS, an innovative, cloud-based Quality and Compliance Management (QMS) solution that will enhance its business quality and clinical management operations.
This new technology integration marks a key milestone in the company’s digital transformation strategy and an important move towards expanding its quality and regulatory capabilities.
The move towards an innovative eQMS digital solution will help streamline critical quality functions like document management, training management, change control, deviation/corrective and preventative action (CAPA), risk management, supplier quality and audit management.
Allyson McLean, Head of Quality Assurance at PHARMExcel, said “With the rise of regulatory demands and challenges in the market, knowing that we have built a robust eQMS solution into our business and clinical processes is peace of mind for me as Head of Quality Assurance. We nurture a culture here that expands beyond standard quality and compliance which means we can offer our clients and partners a better experience including cost efficiencies, transparency and robust risk management.”
Yvanne Enever, CEO at PHARMExcel, stated “We will continue to invest in new solutions and innovative ways of working that add value to our clients and staff. There have been several changes in the pharmaceutical industry over the years, with digital transformation being a key driver in achieving clinical research excellence and improving patient health. As a major player in UK early phase studies, we will continue to invest in our digital infrastructure in order to influence change in the industry”.
PHARMExcel will continue to accelerate its digitisation strategy with the introduction of an enhanced Project Management system, and the launch of a new Clinical Trial Management module next year, which will help further reduce risk and streamline communications between its sponsors and sites to increase visibility into its clinical trial management process.
PHARMExcel is an award-winning, full-service Contract Research Organisation (CRO) providing a flexible and innovative approach to clinical trial delivery. The company is recognised for its in-depth knowledge and experience of the clinical research environment, particularly in the UK, and has a network of regulatory and industry associates, allowing it to provide a global reach.
Media Contact
Katie Howe, Head of Marketing
E: katie.howe@pharmexcel-cro.com
T: +44 (0)20 3642 6654
